Hiroshi Mese

967 total citations
32 papers, 762 citations indexed

About

Hiroshi Mese is a scholar working on Molecular Biology, Oncology and Oral Surgery. According to data from OpenAlex, Hiroshi Mese has authored 32 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Oncology and 8 papers in Oral Surgery. Recurrent topics in Hiroshi Mese's work include Oral and Maxillofacial Pathology (7 papers), Bone health and treatments (4 papers) and Vascular Tumors and Angiosarcomas (3 papers). Hiroshi Mese is often cited by papers focused on Oral and Maxillofacial Pathology (7 papers), Bone health and treatments (4 papers) and Vascular Tumors and Angiosarcomas (3 papers). Hiroshi Mese collaborates with scholars based in Japan, United States and Czechia. Hiroshi Mese's co-authors include Ryuichi Matsuo, Tomohiro Matsumura, Akira Sasaki, Rafael E. Alcalde, Koji Kishimoto, Yasuto Yoshihama, Tsuyoshi Shimo, Goichi Tsukamoto, Takanori Tsuji and Seiji Kondo and has published in prestigious journals such as International Journal of Cancer, Cancer Letters and Neuroscience Letters.

In The Last Decade

Hiroshi Mese

27 papers receiving 743 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Mese Japan 13 399 177 152 102 85 32 762
Nur Mohammad Monsur Hassan Japan 21 368 0.9× 198 1.1× 56 0.4× 123 1.2× 118 1.4× 39 829
Lavanya Balakrishnan India 12 336 0.8× 87 0.5× 75 0.5× 78 0.8× 31 0.4× 22 668
Nicolás Tobar Chile 14 267 0.7× 98 0.6× 81 0.5× 119 1.2× 69 0.8× 29 656
Ulla Westin Sweden 18 206 0.5× 115 0.6× 197 1.3× 123 1.2× 9 0.1× 30 782
Linda McCullagh United States 13 272 0.7× 264 1.5× 157 1.0× 178 1.7× 65 0.8× 17 938
Debora Bencivenga Italy 18 431 1.1× 203 1.1× 55 0.4× 120 1.2× 34 0.4× 36 804
Masaaki Takai Japan 14 269 0.7× 146 0.8× 78 0.5× 96 0.9× 45 0.5× 31 620
Lindsay Coleman United Kingdom 12 733 1.8× 274 1.5× 54 0.4× 198 1.9× 26 0.3× 17 1.4k
Marina Schena Italy 15 179 0.4× 284 1.6× 60 0.4× 94 0.9× 33 0.4× 28 757
Alessandra Di Paola Italy 15 209 0.5× 70 0.4× 73 0.5× 46 0.5× 23 0.3× 35 645

Countries citing papers authored by Hiroshi Mese

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Mese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Mese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Mese more than expected).

Fields of papers citing papers by Hiroshi Mese

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Mese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Mese. The network helps show where Hiroshi Mese may publish in the future.

Co-authorship network of co-authors of Hiroshi Mese

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Mese. A scholar is included among the top collaborators of Hiroshi Mese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Mese. Hiroshi Mese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimo, Tsuyoshi, Kyoichi Obata, Soichiro Ibaragi, et al.. (2017). Maxillofacial Fractures in Elderly Patients. 2(2). 1 indexed citations
2.
Kishimoto, Koji, et al.. (2014). A case of angiosarcoma of the scalp metastasizing to the maxillary gingiva. Japanese Journal of Oral & Maxillofacial Surgery. 60(3). 132–136.
3.
Yoshida, Shoko, Koji Kishimoto, Soichiro Ibaragi, et al.. (2012). A clinical study of patients aged 75 and older with oral squamous cell carcinoma. Journal of Japanese Society of Oral Oncology. 24(3). 103–111. 2 indexed citations
4.
Tsukamoto, Goichi, Hiroyuki Ichikawa, Motoi Kobashi, et al.. (2007). Cisplatin-induced long-term dynorphin A-immunoreactivity in cell somata of rat area postrema neurons. Neuroscience Letters. 424(2). 122–126. 4 indexed citations
5.
Shimo, Tsuyoshi, et al.. (2007). Specific inhibitor of MEK-mediated cross-talk between ERK and p38 MAPK during differentiation of human osteosarcoma cells. Journal of Cell Communication and Signaling. 1(2). 103–111. 47 indexed citations
6.
Mese, Hiroshi & Ryuichi Matsuo. (2007). Salivary secretion, taste and hyposalivation. Journal of Oral Rehabilitation. 34(10). 711–723. 236 indexed citations
7.
Yoshihama, Yasuto, et al.. (2003). Three cases of arterial embolization for bleeding in terminal oral cancer patients. Journal of Japanese Society of Oral Oncology. 15(1). 13–19. 1 indexed citations
8.
Kishimoto, Koji, Akira Sasaki, Yasuto Yoshihama, et al.. (2003). Expression of vascular endothelial growth factor-C predicts regional lymph node metastasis in early oral squamous cell carcinoma. Oral Oncology. 39(4). 391–396. 61 indexed citations
9.
Sawada, Seiji, Hiroshi Mese, Akira Sasaki, Norie Yoshioka, & Tomohiro Matsumura. (2003). Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line. Cancer Chemotherapy and Pharmacology. 51(6). 505–511. 15 indexed citations
10.
Mese, Hiroshi, Akira Sasaki, Koji Kishimoto, et al.. (2002). Clinico-statistical analysis of mucoepidermoid carcinoma.. Journal of Japanese Society of Oral Oncology. 14(1). 11–16. 1 indexed citations
11.
Mese, Hiroshi, Akira Sasaki, Norie Yoshioka, et al.. (2002). Prognostic significance of heat shock protein 27 (HSP27) in patients with oral squamous cell carcinoma. Oncology Reports. 9(2). 341–4. 46 indexed citations
12.
Mese, Hiroshi, et al.. (2001). Analysis of cellular sensitization with cisplatin-induced apoptosis by glucose-starved stress in cisplatin-sensitive and -resistant A431 cell line.. PubMed. 21(2A). 1029–33. 9 indexed citations
13.
Shimo, Tsuyoshi, Satoshi Kubota, Seiji Kondo, et al.. (2001). Connective tissue growth factor as a major angiogenic agent that is induced by hypoxia in a human breast cancer cell line. Cancer Letters. 174(1). 57–64. 78 indexed citations
14.
Sasaki, Akira, et al.. (2001). The E-cadherin gene is silenced by CpG methylation in human oral squamous cell carcinomas. International Journal of Cancer. 93(5). 667–673. 68 indexed citations
15.
Mese, Hiroshi, Yoshiya Ueyama, Atsushi Suzuki, et al.. (2001). Inhibition of Telomerase Activity as a Measure of Tumor Cell Killing by Cisplatin in Squamous Cell Carcinoma Cell Line. Chemotherapy. 47(2). 136–142. 19 indexed citations
16.
Mese, Hiroshi, et al.. (2000). The role of caspase family protease, caspase-3 on cisplatin-induced apoptosis in cisplatin-resistant A431 cell line. Cancer Chemotherapy and Pharmacology. 46(3). 241–245. 24 indexed citations
17.
Nishiyama, Akiko, et al.. (1999). Effects of bisphosphonate on experimental jaw metastasis model in nude mice. Oral Oncology. 35(5). 523–529. 8 indexed citations
18.
Mese, Hiroshi, et al.. (1999). Regulation of Apoptosis Reduction in the Cisplatin-Resistant A431 Cell Line by Bcl-2 and CPP32. Chemotherapy. 46(1). 69–76. 22 indexed citations
19.
Mese, Hiroshi, et al.. (1998). Establishment and Characterization of Cisplatin-Resistant Human Epidermoid Carcinoma Cell Line, A431 Cell. Chemotherapy. 44(6). 414–420. 13 indexed citations
20.
Sasaki, Akira, et al.. (1998). Establishment of High and Low Metastasis Cell Lines Derived from a Human Tongue Squamous Cell Carcinoma. PubMed. 18(5-6). 219–228. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026